New agency to replace South Africa Medicines Control Council
The protection of the people of South Africa against dangerous medicines and related substances depends largely on the existence of an effective and a strong health regulatory authority, said the chairperson of the Portfolio Committee on Health Mary-Ann Lindelwa Dunjwa reported by AllAfrica.
Furthermore, South Africans should always be certain that the medicines and related substances that are on the counters are safe, Ms Dunjwa told Members of the National Assembly (NA MPs) during the recent debate on Medicines and Related Substances Amendment Bill in the National Assembly.
"The amendment of the Medicines and Related Substances Act (101 of 1965) will ensure that people receive medicines that are safe and effective - same as with medical devices that are for good and effective quality," said Ms Dunjwa.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze